Key result
A new bioprosthetic valve designed to achieve greater durability and a larger effective orifice area than existing valves was presented in a first-in-human study.
Answers are grounded in this paper and cite their sources.
This commentary discusses first-in-human results of a novel bioprosthetic valve aiming to combine the durability of mechanical valves with low thrombogenicity.
There is a global need for a prosthetic valve that has the durability of a mechanical valve that minimizes the risks of redo valve replacement yet has low thrombogenicity to avoid the lifelong systemic anticoagulation that is associated with morbidity and mortality. Chen and colleagues1 present the first-in-human results of a new bioprosthetic valve designed to achieve greater durability and a larger effective orifice area (EOA) than existing bioprosthetic valves.2,3
No takes yet. Share an insight, caveat, or question.
Eikelboom et al. (2020) reported an editorial. New bioprosthetic valve was evaluated. A new bioprosthetic valve designed to achieve greater durability and a larger effective orifice area than existing valves was presented in a first-in-human study.
Synapse has enriched 10 related papers. Consider them for comparative context: